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S U M M A R Y
Pakistan is one of the 34 countries that have not achieved the neonatal tetanus (NT) global elimination
target set by the World Health Organization (WHO). NT, caused by Clostridium tetani, is a highly fatal
infection of the neonatal period. It is one of the most underreported diseases and remains a major but
preventable cause of neonatal and infant mortality in many developing countries. In 1989, the World
Health Assembly called for the elimination of NT by 1995, and since then considerable progress has been
made using the following strategies: clean delivery practices, routine tetanus toxoid (TT) immunization
of pregnant women, and immunization of all women of childbearing age with three doses of TT vaccine
in high-risk areas during supplementary immunization campaigns. This review presents the activities,
progress, and challenges in achieving NT elimination in Pakistan.
A review of the literature found TT vaccination coverage in Pakistan ranged from 60% to 74% over the
last decade. Low vaccination coverage, the main driver for NT in Pakistan, is due to many factors,
including demand failure for TT vaccine resulting from inadequate knowledge of TT vaccine among
reproductive age females and inadequate information about the beneﬁts of TT provided by health care
workers and the media. Other factors linked to low vaccination coverage include residing in rural areas,
lack of formal education, poor knowledge about place and time to get vaccinated, and lack of awareness
about the importance of vaccination. A disparity exists in TT vaccination coverage and antenatal care
between urban and rural areas due to access and utilization of health care services. NT reporting is
incomplete, as cases from the private sector and rural areas are underreported. To successfully eliminate
NT, women of reproductive age must be made aware of the beneﬁts of TT vaccine, not only to themselves,
but also to their families. Effective communication strategies for TT vaccine delivery and health
education focusing on increasing awareness of NT are strongly suggested. It is imperative that the private
and government sectors work cooperatively to report NT cases and improve routine TT vaccination
coverage.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. 
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Open access under the Elsevier OA license.1. Introduction
Neonatal tetanus (NT), a highly fatal infection of the neonatal
period, is caused by the bacterium Clostridium tetani. NT develops
when the umbilical cord becomes contaminated with C. tetani
spores as a result of unhygienic delivery or cord care practices after
delivery.1,2 The disease usually occurs in rural settings with poor
access to health facilities.3,4 Surveillance systems do not capture
those NT deaths that occur at home and those for whom medical
care at a hospital was not sought, with birth and death not being
reported.3,4 NT is one of the most underreported diseases5 and
remains a major but preventable cause of infant and neonatal
mortality in many developing countries.6,7* Corresponding author. Tel.: +1 403 329 2676; fax: +1 403 329 2668.
E-mail address: jonathan.lambo@uleth.ca (J.A. Lambo).
1201-9712        2012  International  Society  for  Infectious  Diseases. Published by Elsevier
http://dx.doi.org/10.1016/j.ijid.2012.07.015In 1989, the World Health Assembly called for the elimination
of NT by 1995; by the year 2000, 104 of 161 developing countries
had achieved elimination.8 As of February 2012, Pakistan is one of
the 34 countries that have not achieved maternal and neonatal
tetanus (MNT) elimination.9 The MNT Elimination Initiative, the
global initiative launched by the United Nations Children’s Fund
(UNICEF), World Health Organization (WHO), and the United
Nations Population Fund (UNFPA), continues to spearhead the
effort to eliminate MNT beyond 2005, the target date for
worldwide elimination of the disease.10 However, progress in
global elimination has been delayed due to slow implementation
of the recommended strategies.3,9
To achieve NT elimination, the WHO recommends that
countries conduct surveillance for cases of NT in high-risk areas,
in addition to promoting clean delivery services, routine immuni-
zation of pregnant women, and the ‘high-risk approach’ of
targeting women of childbearing age living in high-risk areas
with three doses of tetanus toxoid vaccine (TT or Td), implemented    Ltd.  Open access under the Elsevier OA license.
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Figure 1. Distribution of neonatal tetanus cases by month of onset and death, Dadu
District, Pakistan, 1993–2003.
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deﬁnes global elimination as an annual rate of <1 case of NT
per 1000 live-births at the district level; maternal tetanus is
considered eliminated when NT is eliminated.10
NT remains a public health problem in Pakistan where it is
estimated that the current reporting system captures less than
10% of cases.11–14 In 1988, 10 countries including Pakistan
accounted for more than 70% of all NT deaths worldwide and were
targeted for focused activities.15 The estimated global number of
NT deaths was 248 000 in 1997, and 26 400 of these deaths were in
Pakistan, with an NT mortality rate of 5 per 1000 live-births.16 By
the year 2008, the WHO estimated that the global NT mortality
had declined to 59 000,17,18 a 92% reduction from the situation in
the late 1980s.17 NT has been actively integrated into the acute
ﬂaccid paralysis (AFP)/polio surveillance infrastructure in
Pakistan; it is hoped that this integration will improve the
reporting efﬁciency of NT and enhance effective monitoring of TT
vaccination coverage.19 Nevertheless, underreporting of NT
remains a public health concern for global elimination and
hinders effective surveillance.19,20
The Government of Pakistan has set the target to eliminate MNT
by 2015.21 The Government is committed to the goal of reducing
the incidence of MNT to <1 case per 1000 live-births in all districts
of the country. To achieve this, the Pakistan National Plan for
Immunization has adopted the ‘high-risk approach’.14 Pakistan has
made good progress in the last 10 years since the high-risk
approach strategy was initiated. By the end of 2010, at least three
rounds of SIAs had been implemented in 54 out of a total of 135
districts, compared to 64 out of a total of 121 districts in Pakistan
by the end of 2003.22 Coverage with the third dose of TT vaccine
was 84% during the ﬁrst phase and 73% during the second phase of
the SIAs conducted between 2001 and 2003.22 This review presents
the activities, progress, and challenges in achieving NT elimination
in Pakistan.
2. Methods
2.1. Literature search
We systematically reviewed the published and gray literature
to assess the NT elimination activities in Pakistan. Medline,
PubMed, EMBASE, Global Health, and Cochrane databases were
searched in January 2012, as were the reference lists of relevant
publications. We used the following combinations of search
terms: (Tetanus OR Tetanus Toxoid OR Clostridium tetani OR
tetanus antibod*) AND (Pakistan*) AND (neonat* OR infan* OR
newborn*). In addition, we searched and extracted information on
immunization coverage from a variety of sources, including the
ofﬁcial WHO reported immunization data, UNICEF, Pakistan
Demographic and Health Surveys, Pakistan Social and Living
Standards Measurement Surveys, and other studies from the
government and private sectors.
2.2. Selection of studies
Studies were included if they focused on the ‘population’ of
neonates and on tetanus in Pakistan. We considered both
randomized trials and observational studies meeting these criteria.
We excluded non-English publications.
2.3. Data extraction
Relevant data were extracted from the identiﬁed studies by
two independent researchers (JL and TN), who also performed
quality assessment using a tool adapted from STROBE (Strength-
ening the Reporting of Observational Studies in Epidemiology).23Information extracted included the location of the study, study
design, sample size, outcome measure, and main results. Results
of the quality assessments were compared and differences
discussed until consensus was reached.
3. Descriptive epidemiology of neonatal tetanus
NT is a highly fatal infection of the neonatal period. C. tetani, the
causative organism, is a ubiquitous bacterium in soil and the
contents of animal and human intestines.2 Contamination of the
umbilical cord may occur through cutting the cord using an
unclean instrument or applying substances containing tetanus
spores to the stump.24 If contamination occurs when the cord is cut
or within the next few days, symptoms begin 3–12 days after
birth.3,25 Tetanus toxin (tetanospasmin), a potent neurotoxin
produced by the vegetative forms of C. tetani, causes increased
irritability of the central nervous system and exaggerated motor
activity by blocking inhibitory neurotransmitters,24 resulting in
muscular stiffness and spasms.24,26
The geographical location of a given country and its climate
inﬂuence the incidence of tetanus.27 The disease often has a focal
distribution, consistently occurring in clusters in geographical
areas and population groups with poor birth hygiene28 and where
shared behaviors or the environment enhance the risk of cord
contamination.13 It commonly occurs in densely populated areas
and hot, humid climates with soil rich in organic matter which
creates favorable conditions for the maintenance of C. tetani.27
NT shows a seasonal pattern with a higher incidence of NT cases
and deaths occurring in the rainy season (July to November peak)
than during the dry season (Figure 1). The rise in monthly case
reports and deaths begins with the onset of the monsoon, usually
in July, peaks between August and October, and falls in November.
This pattern has been observed in India and Pakistan.29–31 There is
speculation that the seasonal increase in NT may be related to an
increased risk of contamination of the cord stump with tetanus
spores in the environment, which becomes increasingly over-
crowded during July to October.30
NT is more prevalent in rural settings with poor access to health
facilities.32 The incidence of tetanus has been found to be 5- to 12-
times higher in rural areas.13,15 In Dadu District, Pakistan, the risk of
NT was found to be 8-times greater in rural than in urban areas.33
However, urbanization and the rapid expansion of cities in Pakistan
have made urban areas increasingly vulnerable to NT.27,34 Urban
areas often have lower NT incidences compared to rural areas due to
better access to care and better hygiene conditions.34,35
Factors inﬂuencing NT mortality rates are age of onset of
symptoms, birth weight, age on admission, age at death, sex
distribution, conditions of antenatal care and delivery, and TT
Figure 2. Neonatal tetanus annual reported cases and TT2 plus (two or more doses of tetanus toxoid vaccine) coverage, Pakistan 1980–2010 (source World Health
Organization43–45).
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mortality surveys in Pakistan have shown that the mean age of
onset for NT varies from 5.5 to 7.3 days,25,36–38 in contrast to the
mean age of onset varying from 5.239 to 6.3 days33 based on
hospital surveillance reports. The incubation period for NT can
vary from 3 to 21 days.1 In Pakistan, an incubation period of 6 days
or less and age on admission of 8 days or less were found to be
signiﬁcantly associated with mortality.33 This mortality risk is
exacerbated for low birth weight neonates.40 Case fatality rates
(CFR) can vary between 10% and 70% depending on treatment, age,
and the health status of the infant.26 The incubation period is
related to the prognosis – the shorter it is, the greater the CFR.40,41
Studies have shown that the CFR may be decreasing due to
targeted TT immunization in Pakistan.33,39 In a previous hospital-
based surveillance report in Pakistan, the mean age at death was
10.7 days.33
There is a higher incidence of male than female
cases.19,20,32,33,42 This has been linked to gender bias in health
care seeking practices and to cultural practices giving preference to
the survival of male children.20,33 Another cause of the higher
incidence of NT among males is that male neonates are
circumcised on or before the 7th day after birth depending on
cultural practices in the area.32
Figure 2 shows the trend in annual NT reported cases and TT2
(two doses of tetanus toxoid vaccine) coverage in Pakistan from
1980 to 2010. The number of NT cases reported declined from 1085
in 1980 to 508 in 2010. Between 1990 and 1999, TT2 immunization
increased 20% and then declined over the course of a decade from
60% in 1999 to 51% in 2008. In 2010, 74% of pregnant women
received a protective course of TT2.43–45
4. Comparative studies of neonatal tetanus in Pakistan
The comparative epidemiological analysis of NT in Pakistan
allowed us to evaluate the following: commonly identiﬁed risk
factors for NT, their relevance to MNT elimination strategies, NT
mortality levels and trends, the impact of TT immunization on NT
mortality, and the role of surveillance in monitoring disease
control efforts. The literature search yielded 29 original articles
that allowed direct comparison because they were all carried out in
different areas of Pakistan, used a similar case deﬁnition of NT for
case ascertainment, and had similar control populations, ifprovided. Excluding case series and case reports, we identiﬁed
nine case–control studies,7,25,34,36–38,46–48 nine cross-sectional
studies,49–57 three community-based mortality surveys,6,31,32
two quasi-randomized trials,39,58 four descriptive studies,19,20,33,59
one community-based randomized trial,60 and one prospective
cohort study61 (Table 1).
4.1. Case–control and community-based studies
Table 2 shows the neonatal mortality rate, NT mortality rate,
TT2 vaccination coverage levels and trends in Pakistan for studies
carried out from 1981 to 2009.6,7,25,31,32,37,38,54,61–67 The NT
mortality survey carried out in the early 1980s can be used for
historical comparison.32 The results illustrate that as neonatal
mortality gradually declines, the proportions of neonatal deaths
due to tetanus decrease. In Pakistan, NT mortality accounted for
17% to 60% of all neonatal deaths. Community-based mortality
surveys further conﬁrmed that mortality rates were highest in
areas where the risk of NT was greatest. A high degree of contact
with C. tetani spores occurs in rural and semi-nomadic areas where
people are engaged in livestock raising and live in close contact
with animals. This facilitates an environment that enhances
exposure to C. tetani spores resulting in the risk of cord
contamination.32 The contribution of NT mortality to all neonatal
mortality was found to vary within and across the provinces, but
was much higher in rural than urban areas (Table 2).
These high-risk areas for NT were the subject of extensive studies
in Pakistan during the 1980s and 1990s. Case–control studies
identiﬁed risk factors for NT by comparing children with and
without NT (Table 1). Analysis of the risk factors has understandably
focused on rural populations where the risk is greatest, but one study
showed that there is also a risk of NT in peri-urban areas.34 With
regard to the policy implications, risk factors identiﬁed in case–
control studies of NT have given rise to opportunities for preventive
measures and priorities in intervention.46
Several studies have identiﬁed a history of NT in a mother’s
previous children as being a signiﬁcant risk factor for NT.36,37,46
Enhanced community-based NT reporting and surveillance may
improve the identiﬁcation of mothers of NT cases and mothers
with a previous NT case. Following implementation of SIAs in high-
risk areas, the WHO recommends enhanced case-based investiga-
tion and case-response activities mounted around each case.68 The
Table 1
Comparative studies of neonatal tetanus in Pakistan
Place Sample size (number of
cases, number of controls)
Main ﬁndings Ref.
Case–control studies
NWFP 69 cases, 207 controls Application of ghee to wound stump, PARa % = 43 38
NWFP 102 cases, 306 controls Application of ghee made in home from cow’s milk (OR 1.94, 95% CI
1.07–3.53)
Non-academically trained delivery attendants (OR 3.90, 95% CI
1.02–14.88)
46
Peshawar, NWFP 100 cases, 300 controls In-use of ghee during the ﬁrst few days of life (OR 1.76, 95% CI 1.02–
3.1)
36
Rural parts of the northern
areas of Pakistan
354 (59 cases, 295 controls) Bundling within the ﬁrst 3 days of life (OR 2.5, 95% CI 1.3–4.9);
PAR% = 23
37
Rural parts of Punjab Province 211 cases, 633 controls Interaction of pre-delivery exposure of mothers to ghee and delivery
on a surface prepared with dried cow dung (OR 5.8)
25
Punjab Province 133 cases, 399 controls The lack of topical antibiotics in circumcision wounds is a signiﬁcant
risk factor of NT (OR 4.2, 95% CI 1.4–12.6)
47
Rural areas of Punjab Province 229 cases, 687 controls Ghee applications to umbilical wounds when heated with cow dung
fuel was signiﬁcantly associated with NT (OR 2.7, 95% CI 1.1–6.6)
48
Loralai District, Balochistan Province 41 cases, 123 controls Risk factors were use of soil as delivery surface (OR 3.2, 95% CI 1.1–
10.2) (PAR% = 64), father’s illiteracy (OR 3.2; 95% CI 1.3–8.1), and
possession of sheep at home (OR 2, 95% CI 1.0–5.0)
7
Karachi, Sindh Province 125 cases, 250 controls Application of substances on umbilical cord (OR 5.1, 95% CI 2.7–9.7)
(PAR% for subsequent cord application = 69), home delivery (OR 1.8,
95% CI 1.1–3.1) (PAR% = 31), and illiterate mother (OR 1.6, 95% CI
1.0–2.0)
34
Cross-sectional studies
Peshawar, NWFP 646 females interviewed;
326 in urban, 320 in
rural areas
TT2 vaccination coverage was 65%
Marital status (OR 8.5, 95% CI 4.7–15.6), visits of LHW to household
(OR 2.3, 95% CI 1.4–3.9), and restriction on TT vaccination (OR 28.7,
95% CI 3.5–237.9) were signiﬁcantly associated with vaccination
status among all females
49
Karachi, Sindh Province 60 females TT vaccination coverage was 40.6%
Inadequate knowledge about TT vaccine among reproductive age
females and inadequate information about the beneﬁts of TT
provided by health care workers and media
50
Lahore District, Punjab Province 362 married females TT2 vaccination coverage in last pregnancy was 87%
Reasons for low coverage were reported as poor knowledge of place
and time to get vaccinated and the importance of vaccination
51
District Bhakkar, Punjab Province 48 TBAs 12% of trained TBAs knew about cord care; no trained or untrained
TBAs had sound knowledge regarding the prophylaxis of NT
52
Karachi, Sindh Province 210 women and
their children
TT2 vaccination coverage for index pregnancy was 57.3%
Reasons for not receiving vaccination were reported as no beneﬁt,
distant vaccination centers, pain due to vaccine, social problems and
fear of harm to fetus
53
Karachi, Sindh Province 565 women TT2 vaccination coverage was 79%; 54.5% of women had 4
antenatal care visits; 56% delivered at a health care facility
54
Hyderabad City, Sindh Province 307 women TT2 vaccination coverage was 40.4%
Reasons for low coverage were lack of formal education (75.2%) and
lack of awareness about the importance of vaccination; LHVs and
LHWs provided information about TT vaccination to 55% of women
55
Karachi, Sindh Province 1407 college/university
females
83.5% of students were aware of tetanus immunization programs
for females of reproductive age; 60.2% were not vaccinated at all;
low immunization coverage despite good awareness of program
56
Kasur District, Punjab Province 104 married women 60% of married women sampled received 2 doses of TT 57
Community-based mortality surveys
Punjab Province, Sindh Province 13 858 live births NT mortality rates were higher in rural areas (34–42/1000 LB)
compared to urban areas (18/1000 LB)
32
Balochistan, NWFP, and FATA 54 834 households Neonatal mortality rate was 57/1000 LB; tetanus accounts for 18.3%
of deaths in the neonatal period
6
Lahore, Pakistan 1476 infants Neonatal mortality rate: 56/1000 LB; NT mortality rate: 9/1000 LB 31
Quasi-randomized trials
Peshawar, NWFP 100 babies Overall CFR was 48%; the case fatality for the treatment group
(pyridoxine) was 23.7% as compared to 55.1% for the control group
39
Lahore, Punjab Province 100 neonates The treatment arm had a CFR of 30% compared to the control arm
with a CFR of 60%
58
Descriptive studies
Loralai district SIAs could prevent 280 cases of NT and 224 deaths from NT; SIAs are
highly cost-effective
59
Dadu District, Sindh Province 408 neonates The use of recapture–capture method in routine surveillance
increased average annual incidence of NT from 0.55/1000 LB to 0.62/
1000 LB; males had higher incidence rates than females
19
Dadu District, Sindh Province 408 neonates Overall completeness of routine reporting was 59.2%; the
proportions of cases reported were 68.1% and 53.8% for government
hospitals and private reporting sites, respectively
20
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Table 1 (Continued )
Place Sample size (number of
cases, number of controls)
Main ﬁndings Ref.
Dadu District, Sindh Province 408 neonates Overall NT CFR was 30%; CFR fell from 42% in 1993 to 29% in 2003;
NT incidence declined from 0.90/1000 LB in 1994 to 0.18/1000 LB in
2003
A strong predictor of mortality was age at admission of 8 days or less
33
Community-based randomized trial
Hala Districts, Sindh Province 8 village clusters
(315 villages, total
population 138 600)
In intervention villages, neonatal mortality rate signiﬁcantly
declined from 57.3 to 41.3 per 1000 LB
60
Prospective population-based cohort study
Latifabad, Hyderabad, Pakistan 1369 pregnant women Causes of neonatal mortality were immaturity-related, birth
asphyxia or hypoxia and infections
61
CFR, case fatality rate; CI, conﬁdence interval; FATA, Federally Administered Tribal Areas; LB, live-births; LHV, lady health visitor; LHW, lady health worker; NT, neonatal
tetanus; NWFP, North West Frontier Province; OR, odds ratio; PAR, population attributable risk %; SIA, supplemental immunization activities; TBA, traditional birth attendant;
TT, tetanus toxoid vaccine; TT2, two doses of tetanus toxoid vaccine.
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with histories of NT cases adds to the burden of NT mortality in the
community. The population attributable risk (PAR %) for NT in a
mother with a previous NT case was estimated to be between 25%
and 33%.36,38
The PAR % for the risk factors cited in several studies, including
bundling (23%),37 soil surface as delivery surface (64%),7 home
delivery (31%),34 and subsequent cord application (69%),34 provide
opportunities for prevention of NT and reduction in the incidence
of NT through modiﬁcation of health-related behaviors including
birth practices.34 Education has an important role to play, as it may
motivate a change in health-related behaviors such as birth
practices and consequently reduce the risk of exposure to the
disease.69 The ﬁnding that the practice of bundling was mainly
linked to the ﬁrst 3 days of life suggests that the risk of umbilical
wound contamination may generally be conﬁned to the ﬁrst few
days of life.37 This calls for the importance of addressing post-
delivery sources of NT, as others have previously suggested.37 We
present a conceptual framework for proximate risk factors and
upstream determinants of NT in Figure 3.
Data from community-based NT mortality surveys and case–
control studies suggest that over 90% of deliveries take place at
home, assisted by relatives in 52–60% of deliveries.7,46 Clean
delivery coverage could be improved by distributing clean delivery
kits to women in rural areas where delivery commonly takes place
at home.54,60 Community-based NT mortality studies showed thatTable 2
Comparison of trends in neonatal mortality, NT mortality, and TT2+ vaccination covera
Year of survey/study Place Neonatal mortality
rate/1000 LB
1981 Punjab Province 52 
1984–1987 Lahore, Punjab Province 56 
1988 NWFP 21 
1990 Rural Punjab Province 18 
1990/1991 All provinces 56 
1991 Rural parts of the
Northern areas
1990–1994 Balochistan and NWFP
including the FATA
57 
1997 Balochistan Province 61 
2003–2005 Hyderabad Sindh Province 47 
2004/2005 All provinces 
2005/2006 All provinces 
2006 Karachi Sindh Province 27 
2006/2007 All provinces 54 
2006/2007 All provinces 
2008/2009 All provinces 
FATA, Federally Administered Tribal Areas; LB, live-births; NT, neonatal tetanus; NWFPbetween 20% and 55%37,38 of NT cases identiﬁed in the community
were seen, diagnosed, and treated by a physician during their
illness. However, it is difﬁcult to speculate on the number of cases
that were actually reported to the routine surveillance system, as
surveillance data suggest substantial underreporting of cases.19,20
In addition, community-based mortality studies provide some
evidence for the effectiveness of maternal immunization in
reducing the risks of NT (Table 2).
4.2. Cross-sectional studies
The cross-sectional surveys of TT vaccination coverage and
knowledge, attitudes, and practices have shown that the main
driver for NT is low maternal tetanus vaccination. These studies
show that only 40.4% to 65% (Table 1) of pregnant women in
Pakistan received a protective course of vaccination with two or
more doses of TT (TT2+);49,55 however surveys conducted between
2005 and 2006 showed that TT2+ coverage ranged from 60% to
65%.49,57 First, this estimate is close to the 53.4% (Table 2) found in
the 2006/2007 Pakistan Demographic and Health Survey (DHS),62
and second, despite the underestimation of administrative
coverage, the trend in annual reported TT2+ coverage seems to
conﬁrm this estimate (Figure 2). However, there was a wide
discrepancy in TT coverage between and within provinces and
districts in Pakistan.51 The trend is that of increasing TT2+ coverage
as conﬁrmed by the Pakistan DHS 1990/9162 and 2006/2007;65 thege
NT mortality
rate/1000 LB
Proportion of
NT mortality %
Maternal TT2+
vaccination
coverage
Ref.
31 60 0 32
9.5 17 - 31
13 62 7 38
11.6 64 7 25
- - 23.3 62
11 11.1 37
10.4 18.3 - 6
23 38 5 7
- - - 61
51 63
62 64
88 54
53.4 65
56 66
68 67
, North West Frontier Province; TT2+, two or more doses of tetanus toxoid vaccine.
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Figure 3. Framework for proximate risk factors and upstream determinants of neonatal tetanus.
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Punjab and Balochistan provinces, respectively.
Our analysis shows that there is a demand failure for TT
vaccine resulting from many factors, including but not limited to
inadequate knowledge of TT vaccine among reproductive age
females and inadequate information about the beneﬁts of TT
provided by health care workers and the media,50 residing in
rural areas,49 lack of formal education,55 and poor knowledge of
place and time to get vaccinated and lack of awareness about the
importance of vaccination.51 Interestingly, knowledge about TT
vaccine, antenatal visits, and visits of lady health workers (LHWs)
have a signiﬁcant impact on TT coverage and were found to be
important factors in the increase in TT vaccination.49 There were
also disproportionate disparities in urban–rural coverage rates in
TT vaccination and antenatal care; the coverage rates were higher
in urban than rural areas.49 The differences in urban–rural
coverage rates, similar to those reported by the Pakistan DHS,62–
64,66,67 may be attributed to access and utilization of health care
services and the health-seeking behavior of urban residents in
comparison to rural residents. For example, 79% of pregnant
women in urban areas compared to only 50% in rural areas sought
antenatal care practices in Peshawar, Pakistan.49 It is also
common for women to have knowledge of the importance of
TT vaccination provided they have access to health care
services.49 Concern has been expressed regarding the ﬁnding
of low TT vaccination coverage despite good awareness of the
immunization program among female students in urban areas.56
This may have important policy implications and reﬂects the
need to reduce the risk of NT in future cohorts of females of
reproductive age by having in place school-based immunization,in combination with the diphtheria–tetanus–pertussis vaccine
given in infancy.
5. Enhancing neonatal tetanus case reporting and surveillance
in Pakistan
5.1. Neonatal tetanus reporting systems in Pakistan
NT is a reportable disease in Pakistan and it is reported
separately from other tetanus cases.19 Pakistan has made rapid
progress towards the elimination of NT. To address the global NT
elimination goal of reducing the NT incidence to <1 case/1000 live-
births in every district in Pakistan, there is the need for better
population-based data on the completeness of reporting of NT,
incidence, and analysis to inform decision-makers who must plan
and implement control measures for NT elimination.19 However,
an assessment of the completeness of ascertainment of disease
reporting systems for NT is difﬁcult for several reasons. First, most
NT deaths occur at home, with birth and death not reported.3
Second, we do not know the proportion of NT cases for whom
health care is sought. And third, despite underreporting, the true
number of NT cases in the community is not known.20 Although
the incidence rates reported in one study are below the global
elimination goal, the surveillance data suggest substantial under-
reporting, as the number of cases and NT incidence rates vary from
one geographical area of a district to another.33
In Pakistan, two separate and parallel surveillance systems are
used to monitor childhood vaccine-preventable diseases including
NT: the Expanded Programme on Immunization (EPI) and the
District Management Information System (DMIS) (formerly the
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the EPI and other reporting systems might have resulted from a
lack of coordination between the EPI and DMIS teams at the district
level with consequent loss of efﬁciency in data correlation.70–72
However, one limitation of the NT data collected through DMIS is
the lack of detailed information on clinical presentation, demo-
graphic details, and immunization status.73 Improvement in the
quality and utility of the data could also be enhanced through
coordination between the DMIS and EPI at the district level. Cross-
border collaboration and cross-notiﬁcation of cases should be
encouraged, as a substantial proportion of unreported NT cases
could be found in tertiary referral hospitals in the areas adjacent to
a district.19
5.2. Data collection, case investigation, and surveillance
Beginning 2004, NT was actively integrated into the AFP/polio
surveillance infrastructure and districts began to include sus-
pected NT and measles in the monthly reports. Data pertaining to
NT are readily accessible in the outpatient department (OPD)
registers, surveillance registers, and immediate report forms of the
EPI surveillance system. The ﬂow of surveillance reports (i.e.,
weekly and monthly) is from the health facility level to the ofﬁce of
the Executive District Health Ofﬁcer to the provincial EPI ofﬁce and
ﬁnally to the federal EPI cell.14,70–72 The provincial EPI cell is
responsible for the dissemination of information to the district
health managers through monthly surveillance reports, and the
current system encourages the participation of pediatricians,
physicians, and the private sector in disease notiﬁcation.70–72 Each
health facility level should report a suspected NT case on the
immediate report form to the district health ofﬁce. At the health
facility level, each reported NT case is supposed to be entered in the
OPD register from which all the cases are abstracted to prepare a
monthly surveillance report. At the district health ofﬁce, the data
are ‘line-listed’.
Clinical signs and symptoms should be recorded on a
standardized case investigation form including information on
gender, disease onset, number of maternal TT vaccine doses,
reporting, and demographic details.68,74 The global elimination
strategy recommends that case-based surveillance and investiga-
tion is vital in districts where TT SIAs have been implemented and
where a decline in the number of cases is occurring.28,74 Beginning
July 2009, AFP zero reporting included suspected cases of measles
and NT. Zero reporting needs to be meaningful; it should not be
seen as a mere absence of cases but as a proxy for active
surveillance.
Our experience suggests that the routine analysis of NT
surveillance data and the monitoring of the surveillance indicators
of completeness and timeliness of reports, and the timeliness of
notiﬁcation to guide program activities at the district level, should
be enhanced. We recognize that these indicators can be readily
estimated from the surveillance data and are not subject to the
inconsistency of a denominator. They have been selected on the
basis of precise deﬁnitions, policy relevance, simplicity, sensitivity,
and time-series data.75 Nevertheless, there is an urgent need to
establish criteria by which to evaluate these indicators so that they
can be monitored routinely in a similar manner to the polio
indicators.
It is recommended that during active surveillance, health
records and vital events registers should be reviewed periodically
(for example, once every 2 weeks).74 This involves searching
actively for suspected NT cases in high-risk districts, especially in
‘silent’ areas where routine surveillance is unreliable or not taking
place at all.74 Surveillance staff have been adequately trained to
use the standard case deﬁnition68 to suspect NT during routine
reviews of infant deaths and illness.Inadequate reviews of medical records may contribute to the
problem of underreporting of NT, as cases may go undetected and
therefore unreported. One study on the NT incidence in Pakistan
found that using active surveillance and register reviews, an
additional 134 cases were found retrospectively.20 These were
cases that were not routinely reported by the health care
professionals as NT cases.20 Although the study did not explore
the reasons for failure to report, it has been hypothesized that
workers may still fear the consequences of reporting.76 Unreported
NT cases that are identiﬁed during reviews of medical records
should be ascertained using the WHO standard case deﬁnition68
and checked if they have not been line-listed in the surveillance
register. Effective implementation of a ‘high-risk’ elimination
strategy will continue to depend on enhanced NT surveillance and
good immunization data to accurately monitor disease trends and
identify those populations and areas where the ongoing risk of NT
is still high.
5.3. Inter-sector collaboration/partnerships
Because the majority of NT cases occur in rural areas and
hospitals, there has been an increasing effort to expand the
reporting sites to include the private sector.19 This includes private
hospitals, clinics, and non-governmental organizations (NGOs) in
rural and urban areas. Some of these sources are already obtaining
their vaccine stocks from the EPI and provide immunization data to
the EPI, so it should not be difﬁcult to enlist their support.
Reporting sites should be prioritized based on the identiﬁcation of
high-risk areas, representativeness, health-seeking behavior, the
diversity and size of the population, and appropriateness of the
designated facility.
Expanding private sector reporting to involve not only the
pediatricians in the urban areas but also the physicians and
pediatricians in the rural areas may be useful to improve
reporting.19 An active promotion of private sector participation
and strengthening of the government sector as a way of improving
NT reporting and surveillance has previously been suggested.20,76
Provision of an adequate supply of resources for reporting,
provision of regular feedback from the health authority to health
care workers, and the availability and widespread use of birth
attendant logs, vital events registries, and standard case deﬁnitions
in hospitals and private reporting sites may also impact NT
reporting and surveillance.20
5.4. Community-based NT reporting: role of the LHWs
In Pakistan, not much has been done using community
informants and village volunteers to report suspected NT cases
and other vaccine preventable diseases. Using health volunteers to
report communicable disease outbreaks has been shown to be
effective in Cambodia.77
The LHW program of the National Programme for Family
Planning and Primary Health Care has been found to be effective in
delivering family planning and immunization services, as well as
the management of diarrhea.78 The success of the LHW program is
primarily due to the unlimited access to households, free
interaction with local women, and most importantly the accept-
ability of LHWs in the communities.79 LHWs were able to change
the poor health care-seeking behavior of women in rural
Pakistan.79 A pilot study by Bhutta et al.60 found that a
community-based intervention for improving perinatal care using
LHWs and traditional birth attendants (TBAs) in villages in rural
Pakistan was effective in reducing stillbirths and neonatal
mortality rates. The intervention consisted of focused training of
LHWs in home-based newborn care, training TBAs in basic
newborn care and community mobilization, and group education
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the last pregnancy was greater (79.2%) than in the control village
(65.9%) following the intervention, which may have consequently
led to an increase in TT immunization during pregnancy in the
intervention village (78.5% vs. 65.5%).60 Overall, the intervention
reduced neonatal mortality from a baseline of 52.3 per 1000 live-
births to 41.3 per 1000 live-births, whereas the neonatal mortality
rate in the control group increased from 52.2 per 1000 live-births
to 59.8 per 1000 live-births. To improve TT coverage, immuniza-
tion programs should be coupled with the LHW program, and
should be implemented as a training core in the curriculum of
LHWs.60
5.5. Methodological issues related to completeness of ascertainment
for NT reporting systems
The current experience with NT reporting and surveillance in
developing countries has highlighted questions about the adequa-
cy of reporting and the usefulness of surveillance in monitoring the
incidence of NT. Underreporting of NT cases may limit the impact
of surveillance on the NT elimination efforts. The development of
effective surveillance through correct and accurate reporting will
not only help to target and evaluate interventions,3 but will also
replace the survey method for obtaining morbidity and mortality
data for NT.12
Although the current reporting system substantially under-
estimates the true number of cases, the two-source capture–
recapture method was recently used to evaluate case ascertain-
ment in the routine surveillance system and to estimate the
incidence of NT in Dadu District, Pakistan.19,20 Several reporting
sources were used with this method: NT surveillance line-list,
case records, and registers in government hospitals, and case
records and registers from private reporting sites. The most
common source of NT reports, routine surveillance, accounted for
only 67% of total reports.20 The proportions of cases reported
were 68.1% for government hospitals and 53.8% for private
reporting sites; 87% of the unreported cases resided in rural
areas.20 Using the two-source capture–recapture method, overall
completeness of routine reporting was 59% for 1993 through
2003,20 and the average annual incidence was 0.62 per 1000 live-
births for the same period.19 Relative to active case ﬁnding, which
is the common method for case validation, capture–recapture
was a useful and less costly way to assess completeness of
reporting routinely.80 However, there are several limitations and
assumptions inherent in the use of the capture–recapture
method.81,82
Methodological issues related to NT reporting and surveil-
lance that need to be addressed include but are not limited to
classiﬁcation of NT according to the WHO recommended case
deﬁnition, retrospective hospital reviews of case reports and
registers, speciﬁcally admission and discharge diagnoses of the
cases, and numerator and denominator data. Other sources of
data that might be useful for case ascertainment of NT are the
DMIS and reporting by community volunteers, LHWs, and TBAs.
Cases reported by the latter groups need further validation using
the WHO standard case deﬁnition68,83 and/or by a physician to
ensure cases are correctly classiﬁed. The NT case deﬁnition is
highly sensitive; however, the sensitivity of the surveillance
system is low due to underreporting.19,84 Routine surveillance
data may provide reliable estimates of NT incidence and
completeness of reporting when the majority of reporting
sources are enhanced and accounted for, which will then feed
into the active surveillance system. The increase in routinely
reported NT cases from 2005 (Figure 2) may be attributed to
the use of the AFP/polio infrastructure to strengthen NT
reporting.6. Improving TT vaccination coverage in Pakistan
To improve TT coverage in Pakistan, changes must be made at
the individual, community, and national level. At the individual
level, support should be provided by health care workers to
childbearing women and their families to ensure that they have an
understanding of NT and TT vaccination. Women must be aware of
the risks and beneﬁts of vaccination and make an informed
decision for themselves and their families. At the community level,
LHWs and TBAs are pivotal in improving TT coverage as they are
both health care professionals and community members who may
also be mothers. Many women seek help from TBAs during
pregnancy.60 Improvements in TBA training in the form of
education regarding TT vaccination and safe cord and delivery
practices would help to reduce NT incidence. By providing
comprehensive training to TBAs, they will be able to educate
their clients about safe health care practices for themselves and
their families. LHWs can impart knowledge regarding vaccination
to women of childbearing age in their communities.56 This can be
accomplished through focus group discussions85 and community
meetings60 to discuss the beneﬁts of vaccination, under the
ideology that women informing and educating other women is
powerful. In addition, community-based education is vital in
strengthening the socioeconomic status and literacy level of
women.86While increased knowledge does not necessarily change
behavior, Afridi et al. found that females lacking knowledge
regarding TT vaccination were less likely to be vaccinated than
those who were knowledgeable.49
At the national and international level, immunization programs
need funding for infrastructure, purchase of vaccines, logistics, and
adequate stafﬁng. Attention should be focused on the reasons
behind why women fail to receive TT vaccinations. For example,
Siddiqi et al. found some women reported not receiving the
vaccination due to a lack of understanding of the beneﬁt, distant
vaccination centers, misunderstanding of the fear of pain arising
from the vaccine, and harm to the fetus.53 The majority of the
reasons for not receiving the vaccination appear to arise from
misunderstanding and a lack of adequate knowledge, rooting from
the illiteracy of the population.53 Intensive health education,
awareness of the risk of NT, and TT vaccination of women of
childbearing age should be targeted to the high-risk districts. To
successfully eliminate NT, changes must be made to all three
agents of socialization.
7. Strengths and limitations
This study is beset with several limitations including incom-
plete NT reporting, as cases from the private sector and rural areas
are underreported, underestimation of cases due to the failure of
health care professionals to report cases, and the use of out-of-date
data sources for mortality and TT vaccination coverage surveys not
reﬂecting the current status of TT vaccination. Strengths of the NT
elimination program in Pakistan include enhanced reporting and
surveillance due to the polio eradication initiative. Routine
surveillance of NT cases is improving due to increased inter-
sector collaboration/partnerships, and an increase in TT vaccina-
tion coverage in Pakistan has resulted from enhanced elimination
activities. The use of multiple data sources allows for a
comprehensive assessment of the current NT elimination activities
in Pakistan.
8. Conclusions
Our study identiﬁed low TT vaccination coverage as the primary
driver of neonatal tetanus in Pakistan. Pakistan has made rapid
progress over the last decade in increasing TT vaccination coverage
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and efforts made so far, it would be cost-effective to focus limited
surveillance resources on monitoring routine TT vaccination
coverage with the goal of bringing coverage to the WHO
recommended standard. It is expected that by building awareness
and understanding of the beneﬁts of TT vaccination, this will
provide support and engage the whole community in the
integration of health education and related promotional materials
into everyday life. It is imperative that the private and government
sectors work cooperatively to report NT cases and improve routine
TT vaccination coverage.
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